Another cancer-related phenotype that is actually the opposite of the antiproliferative and tumor suppressing action of TGF-β, is resistance of cancer cells to chemotherapy, which is enhanced by TGF-β stimulation but also involves independent signaling mechanisms [1]. This evidence concerns the gene TGFB1 and cancer.